Discover 1,727 paid clinical trials in Detroit, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,727
A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
for
Alopecia Areata
Location: Troy MI, Bexley OH, Oakville, Toronto, Indianapolis IN,
Sponsor: Pfizer
Sex: All
Age: 12+
Code: NCT07733765
Phase 3, Recruiting
A Study of Brepocitinib in Adults With Cutaneous Sarcoidosis
for
Cutaneous Sarcoidosis
Location: Troy MI, Ann Arbor MI, Cleveland OH, Fairborn OH,
Sponsor: Priovant Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06978725
Phase 2, Phase 3, Recruiting
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
for
Hidradenitis Suppurativa (HS)
Location: Troy MI, Waterford MI, Ann Arbor MI, London, Waterloo,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06855498
Phase 3, Recruiting
ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG
for
NMIBC
Location: Troy MI, Cynwyd PA, Nashville TN, Atlanta GA,
Sponsor: ImmunityBio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06800963
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
for
Non-Muscle Invasive Bladder Neoplasms
Location: Troy MI, Indianapolis IN, Chicago Ridge IL, Syracuse NY,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07309445
Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
for
Metastatic Castration Sensitive Prostate Cancer (mCSPC),